雜志介紹

Clinical Lung Cancer雜志介紹

《Clinical Lung Cancer》是(shi)一本(ben)(ben)以(yi)English為主的(de)(de)未開放獲取國際優(you)秀期刊(kan)(kan)，中文名稱臨(lin)床肺癌，本(ben)(ben)刊(kan)(kan)主要出版(ban)、報道醫(yi)學-ONCOLOGY領域(yu)(yu)的(de)(de)研究動態以(yi)及在該(gai)(gai)(gai)(gai)領域(yu)(yu)取得的(de)(de)各方(fang)面的(de)(de)經驗和科(ke)研成(cheng)果，介紹(shao)該(gai)(gai)(gai)(gai)領域(yu)(yu)有(you)關(guan)(guan)本(ben)(ben)專業的(de)(de)最新(xin)進(jin)展，探(tan)討行業發展的(de)(de)思路和方(fang)法，以(yi)促進(jin)學術信息交(jiao)流，提高行業發展。該(gai)(gai)(gai)(gai)刊(kan)(kan)已被(bei)國際權威數據庫SCIE收錄(lu)，為該(gai)(gai)(gai)(gai)領域(yu)(yu)相關(guan)(guan)學科(ke)的(de)(de)發展起(qi)到了(le)良好的(de)(de)推動作用，也(ye)得到了(le)本(ben)(ben)專業人員的(de)(de)廣泛認可。該(gai)(gai)(gai)(gai)刊(kan)(kan)最新(xin)影響(xiang)因子為3.3，最新(xin)CiteScore 指數為7。

本(ben)刊近(jin)期中(zhong)國(guo)學者發表的論(lun)文主要有：

• Pathological Stage N1 Limited-Stage Small-Cell Lung Cancer Patients Can Benefit From Surgical Resection

  Author: Yu, Lian; Xu, Jianlin; Qiao, Rong; Han, Baohui; Zhong, Hua; Zhong, Runbo

• The comparison of Lobe-Specific or Systematic Mediastinal Lymph Node Dissection for Early-Stage Lung Adenocarcinoma With Consolidation Tumor Ratio Over 0.5

  Author: Sui, Qihai; Yang, Huiqiang; Yin, Jiacheng; Li, Ming; Jin, Xing; Chen, Zhencong; Jiang, Wei; Wang, Qun

• The Value of Radiotherapy in Patients With Resectable Stage IIIA Non-Small-Cell Lung Cancer in the Era of Individualized Treatment: A Population-Based Analysis

  Author: Liu, Bohao; Wang, Zhiyu; Zhao, Heng; Gao, Shan; Wang, Hongyi; Zhang, Yanpeng; Fan, Kun; Tao, Runyi; Li, Yixing; Feng, Jinteng; Sun, Yuchen; Zhang, Jia; Zhang, Guangjian

• Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor Efficacy and Potential Treatment Strategy

  Author: Fu, Jing; Tong, Yuyang; Xu, Ziguang; Li, Yaonan; Zhao, Ya; Wang, Tao; Li, Cuidan; Cang, Shundong

英文介紹

Clinical Lung Cancer雜志英文介紹

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.